XML 35 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE BENEFIT PLANS
12 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EMPLOYEE BENEFIT PLANS
13.
EMPLOYEE BENEFIT PLANS
 
Retirement Plan - The Riverview Bancorp, Inc. Employees' Savings and Profit Sharing Plan (the "Plan") is a defined contribution profit-sharing plan incorporating the provisions of Section 401(k) of the Internal Revenue Code. Company expenses related to the Plan for the years ended March 31, 2018, 2017 and 2016 were $547,000, $489,000 and $292,000, respectively.
 
Directors' and Executive Officers' Deferred Compensation Plan ("Deferred Compensation Plan") – The Deferred Compensation Plan is a nonqualified deferred compensation plan. Directors may elect to defer their monthly directors' fees until retirement with no income tax payable by the director until retirement benefits are received. The Chairman, President, and Executive and Senior Vice Presidents of the Company may also defer salary into the Deferred Compensation Plan. The Company accrues annual interest on the unfunded liability under the Deferred Compensation Plan based upon a formula relating to gross revenues, which was 3.99%, 3.68% and 3.64% for the years ended March 31, 2018, 2017 and 2016, respectively. The estimated liability under the plan is accrued as earned by the participants. At March 31, 2018 and 2017, the Company's aggregate liability under the plan was $330,000 and $422,000, respectively, which is recorded in accrued expenses and other liabilities in the accompanying consolidated balance sheets.
 
Stock Option Plans - In July 1998, shareholders of the Company approved the adoption of the 1998 Stock Option Plan ("1998 Plan"). The 1998 Plan was effective October 1998 and expired in October 2008. In addition, in July 2003, shareholders of the Company approved the adoption of the 2003 Stock Option Plan ("2003 Plan"). The 2003 Plan was effective in July 2003 and expired in July 2013. Accordingly, no further option awards may be granted under the 1998 Plan or the 2003 Plan; however, any awards granted prior to their respective expiration dates remain outstanding subject to their terms. Each option granted under the 1998 Plan or the 2003 Plan has an exercise price equal to the fair market value of the Company's common stock on the date of the grant, a maximum term of ten years and a vesting period from zero to five years.
 
In July 2017, shareholders of the Company approved the 2017 Equity Incentive Plan ("2017 Plan"). The 2017 Plan provides for the grant of incentive stock options, non-qualified stock options, restricted stock and restricted stock units. The Company has reserved 1,800,000 shares of its common stock for issuance under the 2017 Plan, none of which have been awarded. The 1998 Plan, the 2003 Plan and the 2017 Plan are collectively referred to as "the Stock Option Plans".
 
 The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes stock option valuation model. The fair value of all awards is amortized on a straight-line basis over the requisite service periods, which are generally the vesting periods. The expected life of options granted represents the period of time that they are expected to be outstanding. The expected life is determined based on historical experience with similar options, giving consideration to the contractual terms and vesting schedules. Expected volatility is estimated at the date of grant based on the historical volatility of the Company's common stock. Expected dividends are based on dividend trends and the market value of the Company's common stock at the time of grant. The risk-free interest rate for periods within the contractual life of the options is based on the U.S. Treasury yield curve in effect at the time of the grant. There were no stock options granted during the years ended March 31, 2018, 2017 and 2016 under the Stock Option Plans.
 
As of March 31, 2018, all outstanding stock options were fully vested and there was no remaining unrecognized compensation expense under the Stock Option Plans. There was no stock-based compensation expense related to stock options for the years ended March 31, 2018, 2017 and 2016 under the Stock Option Plans.
 
The following table presents the activity related to stock options under the Stock Option Plans for the years indicated:
 
   
Year Ended March 31,
 
   
2018
   
2017
   
2016
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Number of
Shares
   
Weighted
Average
Exercise
Price
 
Balance, beginning of period
   
220,654
   
$
4.74
     
223,654
   
$
4.73
     
424,654
   
$
8.00
 
Options exercised
   
(59,289
)
   
4.13
     
(3,000
)
   
3.84
     
(18,000
)
   
3.49
 
Forfeited
   
-
     
-
     
-
     
-
     
(29,000
)
   
10.00
 
Expired
   
(20,000
)
   
13.42
     
-
     
-
     
(154,000
)
   
12.92
 
Balance, end of period
   
141,365
   
$
3.77
     
220,654
   
$
4.74
     
223,654
   
$
4.73
 
 
Additional information regarding stock options outstanding as of March 31, 2018 is as follows:
`
           
Options Outstanding
   
Options Exercisable
 
     
Weighted Avg
         
Weighted
         
Weighted
 
     
Remaining
         
Average
         
Average
 
Range of
   
Contractual
         
Exercise
         
Exercise
 
Exercise Price
   
Life (years)
   
Number
   
Price
   
Number
   
Price
 
                                 
$
1.00 - $3.00
     
4.94
     
59,865
   
$
2.71
     
59,865
   
$
2.71
 
$
3.01 - $5.00
     
1.48
     
59,000
     
3.84
     
59,000
     
3.84
 
$
5.01 - $8.00
     
0.47
     
20,000
     
6.17
     
20,000
     
6.17
 
$
8.01 - $9.00
     
0.22
     
2,500
     
8.12
     
2,500
     
8.12
 
         
2.78
     
141,365
   
$
3.77
     
141,365
   
$
3.77
 
 
The following table presents information on stock options outstanding for the periods shown, less estimated forfeitures:
 
   
Year Ended
March 31, 2018
   
Year Ended
March 31, 2017
 
Stock options fully vested and expected to vest:
           
Number
   
141,365
     
220,654
 
Weighted average exercise price
 
$
3.77
   
$
4.74
 
Aggregate intrinsic value (1)
 
$
788,000
   
$
660,000
 
Weighted average contractual term of options (years)
   
2.78
     
3.35
 
Stock options fully vested and currently exercisable:
               
Number
   
141,365
     
220,654
 
Weighted average exercise price
 
$
3.77
   
$
4.74
 
Aggregate intrinsic value (1)
 
$
788,000
   
$
660,000
 
Weighted average contractual term of options (years)
   
2.78
     
3.35
 
                 
         (1) The aggregate intrinsic value of a stock option in the table above represents the total pre-tax intrinsic value (the amount by which the current market value of the underlying stock exceeds the exercise price) that would have been received by the option holders had all option holders exercised. This amount changes based on changes in the market value of the Company's stock.
 
 
The total intrinsic value of stock options exercised was $257,000, $5,000 and $16,000 for the years ended March 31, 2018, 2017 and 2016, respectively.